AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS) Computational, cell biological, and human tissue-based studies establish GPNMB as a risk gene and potential therapeutic target for Parkinson’s Disease (PD), researchers report. PD is a debilitating progressive neurodegenerative brain disorder that affects millions of people worldwide. Diagnosis of the disease often relies on the presence of motor control...